PMID: 8445058Mar 1, 1993Paper

The annual cost of psoriasis

Journal of the American Academy of Dermatology
H M SanderA Menter

Abstract

The need for comparative cost figures for psoriasis therapy has become increasingly important. Our purpose was to compare the yearly costs of various psoriasis treatments. Ten patients were selected for each treatment modality and the average total cost per year, per patient was evaluated. All treatments evaluated were cheaper than inpatient therapy, with Goeckerman treatment in the day-care setting the most expensive and hydroxyurea the cheapest. Cyclosporine, which was used for comparison, was at least twice as expensive as all the other treatments except for Goeckerman treatment in the day-care setting, compared with which it was about 70% more expensive. No single treatment appears to be universally superior to others. In considering specific treatment for psoriasis, cost analyses, including appropriate laboratory and other specialized evaluations, must be taken into account. With use of these data, practitioners and health care organizations may be better able to select appropriate therapy.

References

Feb 1, 1988·The British Journal of Dermatology·T Van JoostM M Meinardi
Nov 1, 1987·Journal of the American Academy of Dermatology·A K Gupta, T F Anderson
Oct 1, 1987·Archives of Dermatology·P E PeckhamJ L McCullough
Jan 1, 1971·Archives of Dermatology·G D Weinstein, P Frost
Apr 1, 1982·Journal of the American Academy of Dermatology·C W Ehmann, J J Voorhees
Oct 1, 1981·Archives of Dermatology·R M AdrianM J Karlin

❮ Previous
Next ❯

Citations

Mar 23, 2004·Journal of the American Academy of Dermatology·Sinead M LanganLouise Barnes
Oct 6, 1997·Clinics in Dermatology·E A Abel
Jun 24, 1993·The New England Journal of Medicine·G G Krueger
Oct 1, 1996·The British Journal of Dermatology·J P Ortonne
May 1, 1994·International Journal of Dermatology·L Nall
Feb 1, 1996·International Journal of Dermatology·L Weinrauch
Dec 3, 2014·The Psychiatric Clinics of North America·Edgardo Rodriguez-Vallecillo, Michel A Woodbury-Fariña
Jul 16, 2008·Expert Opinion on Drug Metabolism & Toxicology·Mei-Lin PangJohn Koo
Jan 26, 2006·Expert Opinion on Pharmacotherapy·Drew W Miller, Steven R Feldman
Nov 29, 2011·Dermatologic Clinics·Kai Li, April W Armstrong
Oct 5, 2010·Cytokine & Growth Factor Reviews·Grant Gallagher
Aug 30, 2008·Clinics in Dermatology·Marc Alexander Radtke, Matthias Augustin
Nov 21, 2007·Clinics in Dermatology·Johann E Gudjonsson, James T Elder
Nov 23, 2012·International Journal of Dermatology·Adrian R LevyCharles W Lynde
May 24, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·T HawroM Maurer
Jan 7, 2000·The American Journal of Medicine·K G Linden, G D Weinstein
Oct 31, 1997·Journal of the American Academy of Dermatology·S R FeldmanA R Clark
Jun 22, 2005·Journal of the American Academy of Dermatology·Steven FeldmanJohn Y M Koo
Nov 1, 1995·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·D R BorehamR E Mitchel
Feb 10, 2006·The Journal of Dermatological Treatment·Daniel J PearceSteven R Feldman
Jan 25, 2011·The Journal of Dermatological Treatment·Mehdi AmirniaAli Hashemi
Nov 10, 2006·The Journal of Dermatological Treatment·Monali J BhosleRajesh Balkrishnan
Jun 10, 1998·The Journal of Investigative Dermatology·A D BurdenD Tillman
Oct 9, 2009·The Journal of Investigative Dermatology·James T ElderRajan P Nair
Sep 25, 2001·Journal of the American Academy of Dermatology·M LebwohlP McClelland
Jul 2, 2005·Expert Opinion on Emerging Drugs·Robert Gniadecki, Martin J Calverley
Oct 17, 2006·Expert Opinion on Investigational Drugs·James VaraniHarrihar A Pershadsingh
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
Oct 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Steven R Feldman, Daniel J Pearce
May 3, 2000·Dermatologic Clinics·A B FleischerS R Rapp
Oct 1, 1997·Journal of Health Psychology·S R RappA Clark
May 22, 2007·Journal of Cutaneous Medicine and Surgery·Richard G LangleyKimberley A Inniss
Nov 13, 2001·The British Journal of Dermatology·S R RappM R Leary
May 29, 1998·The British Journal of Dermatology·E SnellmanJ Luoma
Sep 24, 2004·Dermatologic Therapy·Alice B Gottlieb
Aug 11, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·J M CarrascosaC Ferrándiz
Jun 9, 2005·International Journal of Dermatology·Stephen P McKennaKristijan N Kahler
Mar 7, 2007·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Oliver SchöffskiKristian Reich
Jun 1, 2007·Dermatologic Therapy·Tace SteeleSteven R Feldman
Aug 29, 2003·Expert Opinion on Pharmacotherapy·Steven R FeldmanJeffrey Vallee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
W Robert Lee
The American Journal of Gastroenterology
M D Gelfand
Krankenpflege. Soins infirmiers
Pia Bagnaschi
The New England Journal of Medicine
© 2021 Meta ULC. All rights reserved